English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 21 Help

Selected(0)Clear Items/Page:    Sort:
Quantitative Analysis for Chinese and US-listed Pharmaceutical Companies by the LightGBM Algorithm Journal article
Zheng,Wenwen, Junjun Li,, Wang,Yu, Ye,Zhuyifan, Zhong,Hao, Kot,Hung Wan, Ouyang,Defang, Chan,Ging. Quantitative Analysis for Chinese and US-listed Pharmaceutical Companies by the LightGBM Algorithm[J]. Current Computer-Aided Drug Design, 2023, 19(6), 405-415.
Authors:  Zheng,Wenwen;  Junjun Li,;  Wang,Yu;  Ye,Zhuyifan;  Zhong,Hao; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:1.5/1.5 | Submit date：2023/08/03
Algorithm  Lightgbm  Machine Learning  Pharmaceutical Industry  Quantitative Analysis  r&d  
The gap analysis between Chinese pharmaceutical academia and industry from 2000 to 2018 Journal article
Hao Zhong, Defang Ouyang. The gap analysis between Chinese pharmaceutical academia and industry from 2000 to 2018[J]. Scientometrics, 2020, 122(2), 1113-1128.
Authors:  Hao Zhong;  Defang Ouyang
Favorite | TC[WOS]:5 TC[Scopus]:6  IF:3.5/3.8 | Submit date：2021/03/02
Chinese Pharmaceutical Academia  Gap Analysis  Pharmaceutical Industry  Pharmaceutics  r&d Capacity  
Exploring Technological Complexity in the Pharmaceutical Industry Book chapter
出自: Managing Medical Technological Innovations:World Scientific Publishing, 2020, 页码:219-248
Authors:  Hao Hu;  Liming Zhang
Favorite | TC[Scopus]:0 | Submit date：2022/07/27
Latecomer Firm  Technological Complexity  Pharmaceutical Industry  China  
Obstacles and opportunities in Chinese pharmaceutical innovation Journal article
Ni J., Zhao J., Ung C.O.L., Hu Y., Hu H., Wang Y.. Obstacles and opportunities in Chinese pharmaceutical innovation[J]. Globalization and Health, 2017, 13(1), 21.
Authors:  Ni J.;  Zhao J.;  Ung C.O.L.;  Hu Y.;  Hu H.; et al.
Favorite | TC[WOS]:29 TC[Scopus]:27 | Submit date：2018/11/06
China  Global Network  Innovation  Obstacles  Opportunities  Pharmaceutical Industry  
Innovation Value Chain of Chinese Pharmaceuticals Book
Yitao Wang, Yuanjia Hu, Albert Wai-Kit Chan. Innovation Value Chain of Chinese Pharmaceuticals[M]. 141-07 20th Avenue World Plaza, Suite 604 Whitestone, NY 11357:United States-China Intellectual Property Institute Inc., 2017, 286.
Authors:  Yitao Wang;  Yuanjia Hu;  Albert Wai-Kit Chan
Favorite |  | Submit date：2019/01/14
China  Pharmaceutical Industry  Obstacles  Opportunities  Global Network  Innovation  
Managing the challenges of pharmaceutical patent expiry: a case study of Lipitor Journal article
Chao C.K., Hu H., Zhang L., Wu J.. Managing the challenges of pharmaceutical patent expiry: a case study of Lipitor[J]. Journal of Science and Technology Policy Management, 2016, 7(3), 258-272.
Authors:  Chao C.K.;  Hu H.;  Zhang L.;  Wu J.
Favorite | TC[WOS]:3 TC[Scopus]:5 | Submit date：2018/12/28
Health Care Cost  Lipitor  Patent Expiry  Pharmaceutical Industry  
Pharmaceutical Technology Licensing: An Analysis in the Field of Cardiovascular Disease Journal article
Ni J., Wan J., Kong X., Cai Y., Yang F., Wang Y., Hu Y.. Pharmaceutical Technology Licensing: An Analysis in the Field of Cardiovascular Disease[J]. Journal of Pharmaceutical Innovation, 2016, 11(1), 34.
Authors:  Ni J.;  Wan J.;  Kong X.;  Cai Y.;  Yang F.; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:2.7/2.8 | Submit date：2018/10/31
Cardiovascular Disease  Network  Pharmaceutical Industry  Technology Licensing  
R&D internationalisation patterns in the global pharmaceutical industry: evidence from a network analytic perspective Journal article
Hu Y., Scherngell T., Qiu L., Wang Y.. R&D internationalisation patterns in the global pharmaceutical industry: evidence from a network analytic perspective[J]. Technology Analysis and Strategic Management, 2015, 27(5), 532.
Authors:  Hu Y.;  Scherngell T.;  Qiu L.;  Wang Y.
Favorite | TC[WOS]:17 TC[Scopus]:19 | Submit date：2018/10/31
Pharmaceutical Industry  r&d Networks  Social Network Analysis  
Catch-up of Chinese pharmaceutical firms facing technological complexity Journal article
Hu H., Zhang L.. Catch-up of Chinese pharmaceutical firms facing technological complexity[J]. International Journal of Innovation and Technology Management, 2015, 12(4).
Authors:  Hu H.;  Zhang L.
Favorite | TC[WOS]:9 TC[Scopus]:7 | Submit date：2018/12/28
Latecomer Firm  Technological Complexity  Pharmaceutical Industry  China  
Biopharmaceutical innovation system in China: System evolution and policy transitions (pre-1990s-2010s) Journal article
Hu H., Chung C.-C.. Biopharmaceutical innovation system in China: System evolution and policy transitions (pre-1990s-2010s)[J]. International Journal of Health Policy and Management, 2015, 4(12), 823-829.
Authors:  Hu H.;  Chung C.-C.
Favorite | TC[WOS]:6 TC[Scopus]:8 | Submit date：2018/12/28
Biopharmaceutical  Biotechnology  China  Pharmaceutical Industry  Sectoral Innovation System (Sis)